CHS Inc 8% Preferred Stock
CHSCP
4 hedge funds and large institutions have $670K invested in CHS Inc 8% Preferred Stock in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
33% more funds holding
Funds holding: 3 → 4 (+1)
1% more capital invested
Capital invested by funds: $665K → $670K (+$4.66K)
0.01% less ownership
Funds ownership: 0.2% → 0.18% (-0.01%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VWM
Vermillion Wealth Management
Rosemount,
Minnesota
|
+$5.51K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MSAM
Moloney Securities Asset Management
Manchester,
Missouri
|
-$51.6K |
CHSCP Hedge Fund Activity: Q3 2025 in Review
4 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in CHS Inc 8% Preferred Stock (CHSCP) for Q3 2025, worth a combined $670K — up 0.7% from $665K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new CHSCP positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Vermillion Wealth Management, opening a new position worth an estimated $5.51K. The largest seller was Moloney Securities Asset Management, cutting an estimated $51.6K.
- 4 institutional investors held CHS Inc 8% Preferred Stock (CHSCP) as of Q3 2025, up from 3 in Q2 2025.
- Funds reported $670K of CHS Inc 8% Preferred Stock stock for Q3 2025, up 0.7% quarter-over-quarter.
- 1 fund opened new CHS Inc 8% Preferred Stock positions in Q3 2025 and 0 closed out, a net change of +1 holder.
- The largest CHS Inc 8% Preferred Stock buyer in Q3 2025 was Vermillion Wealth Management, an estimated $5.51K added.
- The largest CHS Inc 8% Preferred Stock seller in Q3 2025 was Moloney Securities Asset Management, an estimated $51.6K sold.
Based on aggregated 13F filings for Q3 2025.